First patent in Japan granted for Neurens trofinetide
Filed with ASX · · 1 page · English
Neuren Pharmaceuticals Limited on 6ix
Story so far
Earlier from Neuren Pharmaceuticals
- Disclosure under Listing Rule 4.3D
- S&P DJ Indices Announces March Quarterly Rebalance
- Preliminary Final Report
- Neuren announces new US patent to be granted for NNZ-2591
- Consolidation/Split - NEU
Later from Neuren Pharmaceuticals
- Neuren announces investment and exclusive negotiation period
- Announcement of buy-back - Appendix 3C
- Neuren and ACADIA announce agreement for North America
- Neuren receives initial payment of US$10 million from ACADIA
- Neuren and Lanstead agree to pause settlements for 120 days
Follow Neuren Pharmaceuticals into a list and get an email when it puts out news.
Follow Neuren Pharmaceuticals